Literature DB >> 33859326

A longitudinal analysis of brain extracellular free water in HIV infected individuals.

Md Nasir Uddin1, Abrar Faiyaz2, Lu Wang3, Yuchuan Zhuang2, Kyle D Murray4, Maxime Descoteaux5, Madalina E Tivarus6,7, Miriam T Weber8, Jianhui Zhong4,6, Xing Qiu3, Giovanni Schifitto8,6.   

Abstract

Initiation of combination antiretroviral therapy (cART) reduces inflammation in HIV-infected (HIV+) individuals. Recent studies demonstrated that diffusion MRI based extracellular free water (FW) modeling can be sensitive to neuroinflammation. Here, we investigate the FW in HIV-infection, its temporal evolution, and its association with blood markers, and cognitive scores. Using 96 age-matched participants, we found that FW was significantly elevated in grey and white matter in cART-naïve HIV+ compared to HIV-uninfected (HIV-) individuals at baseline. These increased FW values positively correlated with neurofilament light chain (NfL) and negatively correlated with CD4 counts. FW in grey and white matter, as well as NfL decreased in the HIV+ after 12 weeks of cART treatment. No significant FW differences were noted between the HIV+ and HIV- cohorts at 1 and 2-year follow-up. Results suggest that FW elevation in cART-naïve HIV+ participants is likely due to neuroinflammation. The correlation between FW and NfL, and the improvement in both FW and NfL after 12 weeks of cART treatment further reinforces this conclusion. The longer follow-up at 1 and 2 years suggests that cART helped control neuroinflammation as inferred by FW. Therefore, FW could be used as a biomarker to monitor HIV-associated neuroinflammation.

Entities:  

Year:  2021        PMID: 33859326     DOI: 10.1038/s41598-021-87801-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  42 in total

Review 1.  Molecular Imaging of Neuroinflammation in HIV.

Authors:  Anna Boerwinkle; Beau M Ances
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

2.  Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits.

Authors:  Linda Chang; Caroline Jiang; Eric Cunningham; Steven Buchthal; Vanessa Douet; Marilou Andres; Thomas Ernst
Journal:  Neurology       Date:  2014-05-21       Impact factor: 9.910

3.  Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.

Authors:  Michael J Peluso; Victor Valcour; Nittaya Phanuphak; Jintanat Ananworanich; James L K Fletcher; Thep Chalermchai; Shelly J Krebs; Merlin L Robb; Joanna Hellmuth; Magnus Gisslén; Henrik Zetterberg; Serena Spudich
Journal:  AIDS       Date:  2017-01-14       Impact factor: 4.177

4.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

5.  Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS.

Authors:  Dima A Hammoud; Christopher J Endres; Ankit R Chander; Tomas R Guilarte; Dean F Wong; Ned C Sacktor; Justin C McArthur; Martin G Pomper
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

6.  Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.

Authors:  Jarek Harezlak; Steven Buchthal; Michael Taylor; Giovanni Schifitto; Jianhui Zhong; Eric Daar; Jeffrey Alger; Elyse Singer; Thomas Campbell; Constantin Yiannoutsos; Ronald Cohen; Bradford Navia
Journal:  AIDS       Date:  2011-03-13       Impact factor: 4.177

Review 7.  Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases.

Authors:  Md Maqusood Alam; Jihye Lee; Sang-Yoon Lee
Journal:  Nucl Med Mol Imaging       Date:  2017-03-16

8.  Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.

Authors:  Alessandro Livelli; Florin Vaida; Ronald J Ellis; Qing Ma; Micol Ferrara; David B Clifford; Ann C Collier; Benjamin B Gelman; Christina M Marra; Justin C McArthur; J Allen McCutchan; Susan Morgello; Ned Sacktor; David M Simpson; Igor Grant; Scott L Letendre
Journal:  Lancet HIV       Date:  2019-06-14       Impact factor: 16.070

9.  The role of TSPO PET in assessing neuroinflammation.

Authors:  Ania A Crawshaw; Neil P Robertson
Journal:  J Neurol       Date:  2017-08       Impact factor: 4.849

Review 10.  Microglial Cells: The Main HIV-1 Reservoir in the Brain.

Authors:  Clementine Wallet; Marco De Rovere; Jeanne Van Assche; Fadoua Daouad; Stéphane De Wit; Virginie Gautier; Patrick W G Mallon; Alessandro Marcello; Carine Van Lint; Olivier Rohr; Christian Schwartz
Journal:  Front Cell Infect Microbiol       Date:  2019-10-24       Impact factor: 5.293

View more
  1 in total

1.  Fixel-Based Analysis and Free Water Corrected DTI Evaluation of HIV-Associated Neurocognitive Disorders.

Authors:  Alan Finkelstein; Abrar Faiyaz; Miriam T Weber; Xing Qiu; Md Nasir Uddin; Jianhui Zhong; Giovanni Schifitto
Journal:  Front Neurol       Date:  2021-11-04       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.